Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
Open Access
- 1 February 1992
- Vol. 33 (2) , 236-241
- https://doi.org/10.1136/gut.33.2.236
Abstract
Increased concentrations of the soluble form of the interleukin 2 receptor have been observed in the sera of Crohn's disease and ulcerative colitis patients. In this study we have observed the spontaneous release of soluble interleukin 2 receptor by unstimulated, isolated normal and inflammatory bowel disease colonic lamina propria mononuclear cells. Lamina propria mononuclear cells from Crohn's disease patients (median = 204 U/ml (interquartile range 126-396, n 17) secreted significantly (p less than 0.01) more soluble interleukin 2 receptor than normal controls (median = 124.5 U/ml (108-131), n 12). No statistically significant differences were seen between ulcerative colitis (median = 135 U/ml (92-196), n 20) and normal controls. Moreover, significantly (p less than 0.01) increased amounts of soluble interleukin 2 receptor were secreted by colonic diverticulitis lamina propria mononuclear cells (median = 259 U/ml (149-282), n 15) which were used as disease specificity controls. Time course experiments showed that the majority of soluble interleukin 2 receptor was released by isolated lamina propria mononuclear cells in the first six days of culture. Upon stimulation with pokeweed mitogen, Crohn's disease (median = 2258 U/ml (1435-3584), n 14), normal control (median = 2622 U/ml (2030-3180), n 14) and diverticulitis lamina propria mononuclear cells (median = 2745 U/ml (1733-3192), n 10) reached similar maximal soluble interleukin 2 receptor secretion levels, while ulcerative colitis lamina propria mononuclear cells secreted significantly (p less than 0.005) less soluble interleukin 2 receptor (median = 912 U/ml (494-1259), n 17). These results suggest that enhanced shedding/secretion of soluble interleukin 2 receptor by intestinal lymphocytes may account in part for increased serum soluble interleukin 2 receptor concentrations during chronic intestinal inflammatory reactions.Keywords
This publication has 26 references indexed in Scilit:
- Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel diseaseGastroenterology, 1991
- Plasma and tissue interleukin-2 receptor levels in inflammatory bowel diseaseClinical and Experimental Immunology, 1990
- Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis.Journal of Clinical Investigation, 1990
- A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.The Journal of Immunology, 1987
- Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.Gut, 1987
- The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic RetrovirusesAnnals of Internal Medicine, 1986
- Antigen-specific murine T cell clones produce soluble interleukin 2 receptor on stimulation with specific antigens.The Journal of Immunology, 1986
- ELEVATED NUMBERS OF PERIPHERAL T-CELLS IN INFLAMMATORY BOWEL DISEASES DISPLAYING T9 ANTIGEN AND FC-ALPHA RECEPTORS1985
- Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.The Journal of Experimental Medicine, 1984
- Differential expression of cell activation markers after stimulation of resting human B lymphocytes.The Journal of Immunology, 1984